Boothbay Fund Management »

Briacell Therapeutics Corp shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Briacell Therapeutics Corp shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $84k 20k 4.19

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Briacell Therapeutics Corp

Citadel Advisors
Armistice Capital
Cable Car Capital
Empery Asset Management
Hudson Bay Capital Management
Warberg Asset Management
Clear Street Group
Iridian Asset Management
Boothbay Fund Management
FNY Investment Advisers

View all funds holding Briacell Therapeutics Corp